{{Rsnum
|rsid=2643217
|Chromosome=15
|position=38711562
|Orientation=plus
|GMAF=0.1194
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 35.1 | 62.2
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.0 | 8.0 | 92.0
| YRI | 0.0 | 2.1 | 97.9
| ASW | 0.0 | 12.3 | 87.7
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 4.6 | 95.4
| GIH | 0.0 | 5.9 | 94.1
| LWK | 0.0 | 0.9 | 99.1
| MEX | 6.9 | 22.4 | 70.7
| MKK | 0.0 | 7.7 | 92.3
| TSI | 9.8 | 43.1 | 47.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=20889312
  |Trait=Bipolar disorder and schizophrenia
  |Title=A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
  |RiskAllele=
  |Pval=6E-6
  |OR=1.27
  |ORtxt=[NR]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}